News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
778,198 Results
Type
Article (53599)
Company Profile (221)
Press Release (724367)
Multimedia
Podcasts (214)
Webinars (30)
Section
Business (244142)
Career Advice (2911)
Deals (37396)
Drug Delivery (230)
Drug Development (85569)
Employer Resources (183)
FDA (17360)
Job Trends (15892)
News (362788)
Policy (34842)
Tag
2025 Best Places to Work (17)
2026 Best Places to Work (25)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 NextGen (1)
2027 Pharm Country Digital (1)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (2961)
Academic (1)
Accelerated approval (74)
ADA (53)
Adcomms (43)
Allergies (227)
Alliances (51753)
ALS (284)
Alzheimer's disease (2095)
Antibody-drug conjugate (ADC) (749)
Approvals (17958)
Artificial intelligence (991)
ASCO (341)
Autoimmune disease (515)
Automation (75)
Bankruptcy (389)
Belgium (44)
Best Places to Work (12002)
BIO (78)
Biologics (116)
BIOSECURE Act (23)
Biosimilars (299)
BioSpace Insights (185)
Biotechnology (134)
Bispecific (60)
Bladder cancer (248)
Brain cancer (96)
Breast cancer (961)
Cancer (7821)
Cardiovascular disease (664)
Career advice (2499)
Career pathing (63)
CAR-T (450)
CDC (79)
CDMO (228)
Celiac Disease (6)
Cell-line development (1)
Cell therapy (1194)
Cervical cancer (66)
Clinical research (76019)
Collaboration (2736)
Commercialization (73)
Company closure (10)
Compensation (1931)
Complete response letters (122)
COVID-19 (3005)
CRISPR (145)
CRO (6)
C-suite (1711)
Cystic fibrosis (175)
Data (10957)
Decentralized trials (4)
Denatured (58)
Depression (223)
Dermatology (206)
Diabetes (830)
Diagnostics (7518)
Digital health (77)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (486)
Drug pricing (247)
Drug shortages (40)
Duchenne muscular dystrophy (378)
Earnings (93190)
Editorial (85)
Employer branding (24)
Employer resources (170)
ESMO (424)
Events (125076)
Executive appointments (1383)
Eye disease (27)
FDA (22322)
Fibrodysplasia Ossificans Progressiva (16)
Fragile X (5)
Friedreich's ataxia (29)
Frontotemporal dementia (41)
Funding (2254)
Gene editing (306)
Generative AI (88)
Gene therapy (934)
GLP-1 (1372)
Government (5147)
Grass and pollen (6)
Guidances (441)
Healthcare (20184)
Hematology (229)
HIV (126)
Huntington's disease (91)
Idiopathic pulmonary fibrosis (15)
IgA nephropathy (154)
Immunology and inflammation (414)
Immuno-oncology (161)
Indications (296)
Infectious disease (3454)
Inflammatory bowel disease (280)
Inflation Reduction Act (16)
Influenza (165)
Intellectual property (384)
Interviews (547)
IPO (17163)
IRA (60)
Job creations (4136)
Job search strategy (2036)
JPM (71)
Kidney cancer (32)
Kidney disease (174)
Labor market (129)
Layoffs (701)
Leadership (69)
Legal (8512)
Licensing (126)
Liver cancer (118)
Longevity (55)
Lung cancer (1089)
Lung diease (27)
Lymphoma (555)
Machine learning (73)
Management (68)
Manufacturing (1576)
Marketing (40)
MASH (256)
Medical affairs (5)
Medical device (14397)
Medtech (14715)
Mergers & acquisitions (21769)
Metabolic disorders (2115)
Middle East (2)
mRNA (326)
Multiple sclerosis (258)
Multispecific (6)
NASH (24)
Netherlands (35)
Neurodegenerative disease (614)
Neuropsychiatric disorders (151)
Neuroscience (4233)
Neurotech (3)
NextGen: Class of 2026 (7006)
Non-profit (4717)
Now hiring (89)
Obesity (1003)
Opinion (397)
Ovarian cancer (292)
Pain (348)
Pancreatic cancer (446)
Parkinson's disease (472)
Partnered (43)
Patents (792)
Patient advocacy (7)
Patient recruitment (962)
Patient selection (114)
Peanut (79)
People (66786)
Peptides (42)
Pharmaceutical (52)
Pharmacy benefit managers (42)
Phase 1 (23607)
Phase 2 (33423)
Phase 3 (25081)
Pipeline (14402)
Policy (421)
Postmarket research (2705)
Preclinical (10074)
Press Release (71)
Prostate cancer (396)
Psychedelics (101)
Radioligand (1)
Radiopharmaceuticals (430)
Rare diseases (1560)
Real estate (6296)
Recruiting (78)
Regenerative medicine (35)
Regulatory (28637)
Reports (70)
Research institute (2655)
Resumes & cover letters (451)
Rett syndrome (60)
RNA editing (35)
RSV (105)
Saudi Arabia (1)
Schizophrenia (229)
Series A (390)
Series B (280)
Service/supplier (7)
Sickle cell disease (147)
Special edition (38)
Spinal muscular atrophy (190)
Sponsored (57)
Startups (3940)
State (2)
Stem cells (7)
Stomach cancer (23)
Substance use disorders (23)
Supply chain (164)
Switzerland (24)
Tariffs (106)
Tax incentives (1)
The Weekly (153)
Vaccines (1396)
Venture capital (177)
Weight loss (669)
Wet AMD (6)
Women's health (181)
Women in leadership (2)
Worklife (28)
Date
Today (218)
Last 7 days (951)
Last 30 days (3800)
Last 365 days (32238)
2026 (29119)
2025 (31159)
2024 (36049)
2023 (40945)
2022 (52274)
2021 (56871)
2020 (55542)
2019 (48425)
2018 (36706)
2017 (34017)
2016 (33738)
2015 (39565)
2014 (33154)
2013 (28403)
2012 (30285)
2011 (30690)
2010 (28450)
Location
Africa (945)
Alabama (117)
Alaska (7)
Arizona (454)
Arkansas (16)
Asia (44617)
Australia (7364)
California (16776)
Canada (4651)
China (1983)
Colorado (743)
Connecticut (729)
Delaware (515)
Europe (98791)
Florida (2586)
Georgia (548)
Hawaii (3)
Idaho (68)
Illinois (1374)
India (148)
Indiana (767)
Iowa (35)
Japan (763)
Kansas (154)
Kentucky (65)
Louisiana (65)
Maine (82)
Maryland (1954)
Massachusetts (11991)
Michigan (414)
Minnesota (913)
Mississippi (7)
Missouri (170)
Montana (35)
Nebraska (30)
Nevada (195)
New Hampshire (88)
New Jersey (4395)
New Mexico (35)
New York (4393)
North Carolina (2144)
North Dakota (14)
Northern California (8625)
Ohio (497)
Oklahoma (28)
Oregon (48)
Pennsylvania (3247)
Puerto Rico (38)
Rhode Island (62)
South America (1282)
South Carolina (102)
South Dakota (2)
Southern California (6770)
Tennessee (278)
Texas (2790)
United States (59093)
Utah (509)
Vermont (2)
Virginia (404)
Washington D.C. (85)
Washington State (1326)
West Virginia (4)
Wisconsin (184)
Wyoming (6)
778,198 Results for "aurinia formerly known as isotechnika pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Podcast
Gilead’s Ouro Buy, J&J/Protagonist’s Approval, Aurinia’s Revamp, ACIP Confusion, More
Gilead continues its dealmaking spree in the sizzling hot space of I&I as Johnson & Johnson, along with partner Protagonist, notched an FDA approval for a new psoriasis drug. Plus, Aurinia Pharmaceuticals gets a new C-suite, FDA releases draft guidance on non-animal models and the CDC’s vaccine advisory committee is not being disbanded after all.
March 25, 2026
·
1 min read
·
Heather McKenzie
Press Releases
Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2026 and Provides Update on Recent Business Progress
October 30, 2026
·
9 min read
Press Releases
Alvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea® 8 mg
October 14, 2026
·
9 min read
Business
Tang Seizes Control of Aurinia, Taking CEO Post in Total Transformation of C-Suite
Healthcare investor Kevin Tang and his allies now hold almost every leadership position at Aurinia Pharmaceuticals, the company at the heart of former CDER Director George Tidmarsh’s exit from the FDA.
March 23, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Nasus Pharma Appoints Nir Sassi as Chief Financial Officer
November 16, 2026
·
5 min read
Press Releases
Aurinia Announces Management Transition
March 23, 2026
·
1 min read
Earnings
AbbVie’s Q3 beat should keep ‘train rolling’ as company eyes bolt-on deals
Strong immunology and neuroscience sales fueled AbbVie’s latest quarterly beat as the pharma’s stock continues to hit all-time highs.
October 30, 2026
·
3 min read
·
Gabrielle Masson
Mergers & acquisitions
After Missing Kezar Buyout in 2024, Tang Returns as CEO of Aurinia With $50M Offer
Serial biotech investor Kevin Tang previously unsuccessfully tried to buy Kezar Life Sciences via Concentra Biosciences, a biotech consolidation company owned by the venture capital firm he runs.
March 30, 2026
·
2 min read
·
Annalee Armstrong
China
As pharma descends on China for deals, BIOSECURE Act raises intellectual property risk
When signing a biotech licensing deal in China, experts say that pharma’s patent attorneys need to understand the geopolitical risk of the BIOSECURE Act.
July 28, 2026
·
7 min read
·
Annalee Armstrong
Job Trends
Behind the scenes of 3 Big Pharma layoffs
Three former employees of large pharmas, including Novo and Sanofi, share how they were let go. While they appreciated some aspects of their experiences, such as severance and outplacement resources, they criticized a lack of public transparency, a mishandled notification and puzzling outsourcing.
October 28, 2026
·
5 min read
·
Angela Gabriel
1 of 77,820
Next